Acute Lymphoblastic Lymphoma: Clinical Trials

3 trials for Acute Lymphoblastic Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 unknown. 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 21Active not recruiting 1
Phase 31Active not recruiting 1

Follow Acute Lymphoblastic Lymphoma: new trials by email Literature Review of Acute Lymphoblastic Lymphoma trials Research Report on Acute Lymphoblastic Lymphoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)
200 cGy or 400 cGy total body irradiation (TBI) - Acute Leukemia, Acute Lymphoblastic Lymphoma
Not applicableRecruitingSidney Kimmel Comprehensive Cancer Center at Johns Hopkins1602025-03-272026-04-06
Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired Protocol
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma
UnknownAssistance Publique - Hôpitaux de Paris3002021-01-012020-12-21
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
Prednisone, Vincristine, Daunorubicin - Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma
Phase 2 / Phase 3Active not recruitingSt. Jude Children's Research Hospital7902017-03-292026-06-17

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Leukemia (1)  ·  Lymphoma (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Leukemia (1)

Interventions

Asparaginase (1)  ·  Bortezomib (1)  ·  Calcium Dobesilate (1)  ·  Clofarabine (1)  ·  Cyclophosphamide (1)  ·  Cytarabine (1)  ·  Dasatinib (1)  ·  Daunorubicin (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Idarubicin (1)  ·  Mercaptopurine (1)  ·  Methotrexate (1)  ·  Prednisolone (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)  ·  St. Jude Children's Research Hospital (1)

Countries

United States (2)  ·  Australia (1)

Top investigators

Hiroto Inaba, MD, PhD (1)  ·  Jonathan Webster (1)

Results publications

PMID 42154791